Analysis of the pharmaceutical supply system for assisted reproductive technologies in Ukraine and the world

Authors

DOI:

https://doi.org/10.24959/sphhcj.18.129

Keywords:

assisted reproductive technologies, pharmaceutical supply, marketing analysis, hormonal drugs, formulary

Abstract

Aim. To analyze the domestic pharmaceutical market of hormonal drugs for assisted reproductive technologies in accordance with the treatment protocols and with the comparison with the State Formulary of Medicines of Ukraine and the British National Formulary.

Materials and methods. The study was conducted on the basis of data from the clinical protocols on Assisted Reproductive Technologies (ART), the State Register of Medicinal Products of Ukraine, electronic databases, the Weekly Pharmacy on June 30, 2018, the State Formulary of Ukraine and the British National Formulary. The system, marketing, analytical and comparative analysis methods were used in the research.

Results. The system legal support of assisted reproductive technologies in Ukraine has been established in accordance with the European conventions. It has been determined that the list of medicines for ART includes 14 trade names. The marketing analysis has shown that among 45 trade names registered there are single-source ones, such drugs as Puregon®, Pergoveris®, Ovitrel®, Klostilbegit®, Orlutran®, Tsetrotid®; therefore, the pharmaceutical development of these drugs is promising. Among the study list of INNs in the State Formulary of medicines of Ukraine there are no medicines, such as Choriogonadotropin alfa (Ovitrelle®), Corifollitropin alfa (Elonva®), fixed combination of Follitropin alfa / Lutropin alpha (Pergoveris 150/75®) with evidence based effectiveness; therefore, it is advisable to expand the list of hormonal drugs in the State Formulary of Ukraine.

At the expense of budget funds in Ukraine it is financed in the range of 2.4-32.6 % of the need for reproductive health programs. It is necessary to increase funding to provide the need in hormonal drugs for ART.

Conclusions. The results of marketing research can be used for reviewing the State Formulary of Ukraine, for practical measures on the effective implementation of public procurement to increase the availability of ART in Ukraine.

Author Biographies

Kh.-O. Ya. Stasiv, Danylo Halytsky Lviv National Medical University

teaching assistant of the Department of Management and Economy of Pharmacy, Medicine Technology
and Pharmacoeconomics of the Postgraduate Faculty

O. M. Zaliska, Danylo Halytsky Lviv National Medical University

Doctor of Pharmacy (Dr. habil.), professor, head of the Department of Management and Economy of Pharmacy,
Medicine Technology and Pharmacoeconomics of the Postgraduate Faculty

N. M. Maksymovych, Danylo Halytsky Lviv National Medical University

Candidate of Phamacy (PhD), senior lecturer of the Department of Management and Economy of Pharmacy,
Medicine Technology and Pharmacoeconomics of the Postgraduate Faculty

References

Payne, C. L. (2016). The International Covenanton Civil and Political Rights and the strategic shift to forced disappearance. Journal of Human Rights,15 (2), 163-188. doi: 10.1080/14754835.2015.1103158.

Postanova KMU vіd 27 grudnia 2006 No. 1849 “Pro zatverdzhennia Derzhavnoi programy “Reproduktivne zdorov’ia natsіi” na perіod do 2015 roku”. Available at: http://zakon5.rada.gov.ua/laws/show/1849-2006-p

Milevska, N. V. (2016). Zhinochyi likar, 6, 8-12. – Available at: https://z-l.com.ua/ru/newsid/2158.

Nakaz MOZ Ukrainy No. 787 vіd 09.09.2013 (2014). “Pro zatverdzhennia Poriadku zastosuvannia dopomіzhnykh reproduktyvnykh tekhnolohіi v Ukrainі” (Іz zmіnami, vnesenymy zgіdno z Nakazom Mіnіsterstva okhorony zdorov’ia No. 165 vіd 06.03.2014). Zbіrnyk normatyvno-dyrektyvnykh dokumentіv z okhorony zdorov’ia, 5, 4−40.

Іnformatsіino-statystychnyi dovіdnik pro dopomіzhnі reproduktyvnі tekhnolohіi v Ukrainі. Available at:http://www.uarm.org.ua/component/attachments/download/89.html

Postanova KMU vіd 23 serpnia 2016 No.557 “Pro zatverdzhennia pereliku likarskykh zasobiv ta medychnykh vyrobiv, yaki zakupovuiutsia na pidstavi uhod (dohovoriv) shchodo zakupivli iz spetsializovanymy orhanizatsiiamy, yaki zdiisniuiut zakupivli za napriamamy vykorystannia biudzhetnykh koshtiv u 2016 rotsi za biudzhetnoiu prohramoiu 2301400 “Zabezpechennia medychnykh zakhodiv okremykh derzhavnykh prohram ta kompleksnykh zakhodiv prohramnoho kharakteru”. Available at: https://www.apteka.ua/article/383101

Konoshevych, L. V., Tikhonov, O. І., Shpichak, O. S. (2017). Sotsіalna farmatsіia v okhoronі zdorov’ia, 3 (2), 60-69. doi: 10.24959/sphhcj.17.77.

Kotvitska, А. А., Lobova, І. О. (2015). The study of development trends of the pharmaceutical market of neuroprotective drugs in Ukraine. Sotsіalna farmatsіia v okhoronі zdorov’ia, 1 (2), 73-81. doi: 10.24959/sphhcj.15.22.

Kotvіtska, A. A., Korobova, Ye. S. (2016). Sotsіalna farmatsіia v okhoronі zdorov’ia, 2 (4), 24-31.doi: 10.24959/sphhcj.16.57.

Derzhavnii reestr lіkarskykh zasobіv Ukrainy. Available at: www.drlz.kiev.ua.

Published

2018-12-12

Issue

Section

Health organization